In the above-mentioned article, some of the author’s duality of interest disclosures were inadvertently omitted from the manuscript. The complete disclosure statement should have read:

S.S. is a member of the American Gastroenterological Association Institute’s council section for Obesity, Metabolism, and Nutrition, an advisory board member for the Association for Bariatric Endoscopy, and vice president of The Obesity Society’s Bariatric Section. She is also currently a consultant for Obalon Therapeutics, Aspire Bariatrics, USGI Medical, and Spatz FGIA. In the past 12 months, she has performed contracted research through her institution for Aspire Bariatrics, Obalon Therapeutics, and Allurion Technologies. No other potential conflicts of interest relevant to this article were reported.

The online version of the article was corrected on 4 December 2017 to reflect this change.

View Original Article
© 2018 by the American Diabetes Association.
2018
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.